A Response to the Letter to the Editor: "Can We Refine Criteria for the First-Line Treatment for Patients With Advanced ALK-Positive NSCLC in the Real World?".
作者信息
Lam Vincent K, Gadgeel Shirish M
机构信息
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland; Bloomberg∼Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, Maryland.
Henry Ford Cancer Institute, Henry Ford Health Center, Detroit, Michigan.
出版信息
J Thorac Oncol. 2025 Jun;20(6):e73. doi: 10.1016/j.jtho.2025.03.049.
PMID:40484493
Abstract
摘要
Zotero 插件